SCHEMBL4031735

SCHEMBL4031735

CC1(C)C(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C(=O)N1Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.59
MEN1 O00255 1/20 0.59
LMNA P02545 1/20 0.59
TP53 P04637 1/20 0.59
CYP1A2 P05177 1/20 0.59
PGR P06401 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
TSHR P16473 1/20 0.59
ALOX12 P18054 1/20 0.59
NFKB1 P19838 1/20 0.59
CYP2C19 P33261 1/20 0.59
RAB9A P51151 1/20 0.59
KMT2A Q03164 1/20 0.59
PDE4D Q08499 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
SIRT6 Q8N6T7 1/20 0.47
IGF1R P08069 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025724 0.86 AR (0.69) ARMEN1LMNATP53CYP1A2
SCHEMBL633883 0.85 AR (0.64) ARMEN1LMNATP53CYP1A2
SCHEMBL634846 0.85 AR (0.64) ARMEN1LMNATP53CYP1A2
SCHEMBL633665 0.84 AR (0.62) ARMEN1LMNATP53CYP1A2
SCHEMBL634148 0.84 AR (0.62) ARMEN1LMNATP53CYP1A2
SCHEMBL633318 0.84 AR (0.62) ARMEN1LMNATP53CYP1A2
SCHEMBL633664 0.84 AR (0.62) ARMEN1LMNATP53CYP1A2
SCHEMBL633848 0.84 AR (0.62) ARMEN1LMNATP53CYP1A2
SCHEMBL7779075 0.84 AR (0.62) ARMEN1LMNATP53CYP1A2
Hydrochloric Acid SCHEMBL22656815 0.82 AR (0.60) ARMEN1LMNATP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009097996-A1 USE OF SUBSTITUTED PHENYLIMIDAZOLIDINES FOR PRODUCING MEDICAMENTS FOR TREATING METABOLIC SYNDROME SANOFI-AVENTIS (FR) 2009-08-13 WO disclosed
US-RE35956-E Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1998-11-10 US disclosed
US-5627201-A Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1997-05-06 US disclosed
US-5411981-A Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1995-05-02 US disclosed